IP Cases — 2024
6,517 decisions across all jurisdictions
Page 50 of 218 · 6,517 total
Western Digital Technologies, Inc. et al. v.Godo Kaisha IP Bridge 1
Director Review requests were issued for IPR2024-01493 and IPR2024-01494, limiting petitioner responses to five pages and prohibiting new evidence.
Western Digital Technologies, Inc. et al. v.Godo Kaisha IP Bridge 1
The PTAB denied Western Digital's request for Director Review of the institution decisions in three IPRs, including the case involving patent 11,968,909. The institution rulings therefore remain in place.
Western Digital Technologies, Inc. et al. v.Godo Kaisha IP Bridge 1
The PTAB Director has issued a Director Review request for two IPRs involving Western Digital and Godo Kaisha IP Bridge 1. The petitioner must respond within five business days with a brief limited to the raised issues and cannot submit new evidence.
Therabody, Inc. v.Hyperice IP Subco, LLC et al.
Therabody has filed a post‑grant review petition seeking cancellation of 14 claims of Hyperice’s percussive‑massager patent, alleging lack of written description, indefiniteness, and obviousness over multiple prior‑art references.
Western Digital Technologies, Inc. et al. v.Godo Kaisha IP Bridge 1
Western Digital has filed an IPR petition challenging all 20 claims of the ’909 MRAM patent owned by Godo Kaisha IP Bridge. The petition argues the claims are obvious over prior‑art MTJ publications, and disputes any discretionary denial.
Western Digital Technologies, Inc. et al. v.Godo Kaisha IP Bridge 1
Western Digital petitions the PTAB to invalidate 15 claims of a MRAM patent, arguing they are obvious over known MTJ teachings. The petition cites Bowen, Nagahama, Sunai, Parkin and Soukup as prior art and challenges discretionary denial.
Samsung Electronics Co., Ltd. et al. v.Truesight Communications LLC
Samsung has filed an IPR petition seeking cancellation of all 14 claims of Truesight’s ’803 patent, arguing that the claims are obvious over a combination of eight prior‑art references covering kiosk‑based streaming, authentication, and removable media.
Therabody, Inc. v.Hyperice IP Subco, LLC et al.
Therabody, Inc. successfully convinced the PTAB to institute proceedings against Hyperice IP Subco, LLC regarding a medical device patent (11857482). The Board found prima facie evidence of obviousness and indefiniteness across multiple claims based on prior art combinations.
Western Digital Technologies, Inc. et al. v.Godo Kaisha IP Bridge 1
Western Digital Technologies successfully convinced the PTAB to institute review on 16 claims against Godo Kaisha IP Bridge 1's patent (11968909). The Board found sufficient support for obviousness over Bowen and Soukup, particularly regarding Claim 5.
Western Digital Technologies, Inc. et al. v.Godo Kaisha IP Bridge 1
Western Digital Technologies successfully convinced the PTAB that its claims against Godo Kaisha IP Bridge 1 were non-obvious, leading to the institution of trial on all claims. The Board found a reasonable likelihood of prevailing on Claim 1 based on combinations of Bowen and Sunai prior art.
Samsung Electronics Co., Ltd. et al. v.Truesight Communications LLC
The PTAB denied Samsung's IPR petition against Truesight's patent (8898803), citing the advanced stage and proximity of related District Court litigation.
Therabody, Inc. v.Hyperice IP Subco, LLC et al.
Therabody challenged Hyperice's patent on percussive massagers based on indefiniteness and obviousness, but the PTAB upheld the claims. The Board found that key terms like 'substantially cylindrical' were supported by functional limitations in the specification.
T-Mobile Usa Inc v.Controller Of Patents
This order pertains to an appeal filed by T-Mobile Usa Inc against the Controller of Patents. The matter involves the interpretation of Section 3(k) of the Patents Act, 1970, and was released from part-heard due to roster constraints.
Master Arnesh Shaw v.Union of India & Anr.
The matter concerns the cumbersome and long-drawn process for procuring specialized medicines for DMD patients on a patient-by-patient basis. The court directed M/s. Sarepta Therapeutics to present a general, bulk procurement process and disclose all its relevant patents and patent applications in India.
Master Arnesh Shaw v.Union Of India & Anr.
The court heard multiple connected matters concerning the procurement of rare disease medicines, specifically those used for DMD patients. The petitioner argued that the current patient-to-patient process is extremely cumbersome and inefficient. Consequently, the court directed M/s. Sarepta Therapeutics to present a bulk procurement process and disclose its relevant patent information.
Master Arnesh Shaw Through His Next Friend And ... v.Union Of India & Anr.
The petition addressed the cumbersome and long-drawn process for procuring specialized medicines for DMD patients on a patient-by-patient basis. The court directed M/s. Sarepta to document a bulk procurement process and provide details of all its relevant Indian patents and patent applications.
Master Arnesh Shaw v.Union Of India & Anr.
The petition addressed the extremely cumbersome and long-drawn process for procuring specialized medicines on a patient-by-patient basis. The court directed M/s. Sarepta Therapeutics to place on record a general bulk procurement process and provide details of all its granted patents and patent applications in India related to DMD patients.
Master Arnesh Shaw v.Union Of India & Anr.
The petition addressed the extremely cumbersome and long-drawn process for procuring rare disease medicines on a patient-by-patient basis. The court directed M/s. Sarepta Therapeutics to place on record a general bulk procurement process and provide details of all its granted patents and patent applications filed in India concerning DMD patients.
Master Arnesh Shaw v.Union Of India & Anr.
The petition addressed the extremely cumbersome and long-drawn process for procuring specialized medicines for DMD patients on a patient-by-patient basis. The court directed M/s. Sarepta Therapeutics to place on record a general bulk procurement process and provide details of all its granted patents and patent applications in India related to these medicines.
Master Drashtant Jhala Through His Next Friend and Natural Father Sh. Jaydeep Singh Jhala v.Union of India & Anr.
The petition addresses the extremely cumbersome and long-drawn process for procuring rare disease medicines on a patient-by-patient basis. The court directed M/s. Sarepta Therapeutics to place on record a general bulk procurement process and provide details of all its granted patents and patent applications in India related to DMD patients.
Master Arnesh Shaw v.Union Of India & Anr.
The court heard matters concerning the procurement process for medicines used for DMD patients, noting that the current patient-by-patient system is cumbersome and unrealistic. The court directed M/s. Sarepta Therapeutics to present a general bulk procurement process and disclose its relevant patent portfolio in India.
Master Arnesh Shaw v.Union Of India And Ors.
The petition concerns the cumbersome and long-drawn process for procuring specialized medicines for DMD patients on a patient-by-patient basis. The court directed M/s. Sarepta Therapeutics to place on record its general bulk procurement process and provide details of all granted patents and patent applications in India related to these medicines.
Lakshay Agarwal v.Union Of India & Anr.
The petitioner raised concerns regarding the extremely cumbersome and long-drawn process for procuring specialized medicines on a patient-to-patient basis. The court directed M/s. Sarepta Therapeutics to place on record the general bulk procurement process and provide details of all its granted patents and patent applications filed in India concerning DMD medicines.
Ashok Bhutani v.The Registrar Of Trade Marks & Anr.
Ashok Bhutani successfully challenged the Trademark Registry in the Delhi High Court regarding the non-renewal of his word mark 'SNOWPEAK'. The petitioner argued that the failure to receive mandatory O-3 notices prevented him from filing timely renewal applications. Recognizing the registry's lapse, the court directed the respondents to issue all pending renewal certificates and subsequently restore and renew the trademarks for a further ten-year period.
Dolby International AB v.Optoma Corporation, Optoma Deutschland GmbH, Optoma Europe Ltd.
Dolby International AB filed a patent infringement action against Optoma entities before the Local Chamber Düsseldorf concerning European Patent EP 3 605 534. Before the defendants' deadline to respond or file a counterclaim for revocation, the plaintiff withdrew the action following an out-of-court settlement. The defendants consented to the withdrawal and the plaintiff's cost proposals, and the court issued an order terminating the proceedings.
Panasonic Holdings Corporation v.Xiaomi Inc. et al.
This is a procedural order from the Local Chamber Munich of the Unified Patent Court in a patent infringement action concerning EP3024163, owned by Panasonic Holdings Corporation, against ten Xiaomi entities. The defendants sought a stay of proceedings under Rule 295(l) and/or (m) RoP pending the UK High Court of Justice's decision on the final terms of a FRAND license agreement. The presiding judge and rapporteur referred the matter to the full panel, proposing that the decision be made during or after the already scheduled oral hearings in late November 2024 and late January 2025.
Tableau Software, LLC et al. v.iCharts LLC
iCharts LLC filed an authorized response urging the PTAB Director to deny Tableau Software’s request for director review of the institution decision. The response emphasizes that the dissent does not merit reversal and that Tableau failed the reasonable‑likelihood test under 35 U.S.C. § 314(a).
Tableau Software, LLC et al. v.iCharts LLC
The PTAB Director denied Tableau Software's request for review of the institution decision in IPR2024-01389, leaving iCharts LLC's patent 8,520,000 intact.
Tableau Software, LLC et al. v.iCharts LLC
Tableau Software has filed a request for Director Review to overturn the PTAB’s denial of institution of an IPR against its interactive‑chart patent. The petition contends the Board erred on claim constructions, the disclosure of a second website, and motivation to combine prior art references.
Tableau Software, LLC et al. v.iCharts LLC
Tableau Software seeks Director Review of a PTAB decision denying institution of its IPR against iCharts’ interactive‑chart patent. The petitioner contends the Board erred on claim constructions, motivation to combine, and QlikView disclosures.
Facing a similar IP matter?
Arctic Invent is a specialist IP firm with deep litigation expertise across India, EU, US, and UK. Our team uses data-driven strategy to build stronger cases.